Earnings call AbbVie delivered Q2 2026 adjusted EPS of $3.65 (up $0.06 vs guidance midpoint) and net revenues of nearly $17B (+10.2% YoY), driven by double-digit growth in immunology and neuroscience.

Good morning, and thank you for standing by. Welcome to the AbbVie Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Today's call is also being recorded. If you have any objections ...

AbbVie ABBV is set to report second-quarter 2026 earnings on July 31, before the opening bell. The Zacks Consensus Estimate ...

Though Botox is not yet approved by the Food and Drug Administration (FDA) for trigeminal neuralgia (TN), doctors sometimes use Botox injections “off-label” as a treatment option for TN. Botox is ...

An iconic actor's secret ex-boyfriend said, "We were ordered never to have our picture taken together, because somebody would ...

Dermatologists weigh in on the injectable trend ...

The uproar roiling international football in the wake of FIFA’s plans to sell a stake in its new media division got its start ...

BGN, a little-known trading house with Turkish roots, has emerged as one of the top players in the market for Kazakhstan’s ...

The outspoken Dunkin' loyalist (and official ambassador for the coffee chain) has given us some truly memorable moments on behalf of the brand Stephanie Sengwe is a pop culture enthusiast with over 10 ...

In dental hygiene commercials, models dramatically squeeze a giant glob of toothpaste across their perfectly bristled brushes as they convincingly brush their already pearly-white teeth. Marketing ...